&nbsp;

Poster-mciq.zip

Jul 2025

Document

pebcES1-25f.pdf

New

Sep 2025

Regimen

FLVSINAVPALB

Cancer Type:

Breast

Intent: Palliative

Funding:

ODB - General Benefit

fulvestrant

Drugs Used:

inavolisib (Unfunded),

palbociclib (Unfunded),

fulvestrant

Quick Link(s):

Regimen Monograph

Oct 2025

Regimen

PEMB

Cancer Type:

Head and Neck,

Squamous Cell

Intent: Neoadjuvant, Curative

Drugs Used:

pembrolizumab (Unfunded)

Quick Link(s):

Regimen Monograph

Sep 2025

Regimen

PEMB(RT)

Cancer Type:

Head and Neck,

Squamous Cell

Intent: Adjuvant, Curative

Drugs Used:

pembrolizumab (Unfunded)

Quick Link(s):

Regimen Monograph

Sep 2025

Regimen

PEMB

Cancer Type:

Head and Neck,

Squamous Cell

Intent: Adjuvant, Curative

Drugs Used:

pembrolizumab (Unfunded)

Quick Link(s):

Regimen Monograph

Oct 2025

First Nations, Inuit, Métis and Urban Indigenous Cancer Strategy (2024 to 2028)

Document

FrequentlyAskedQuestions-OCRSEERStat14.pdf

New

Dec 2025

Document

FrequentlyAskedQuestions-OCRSEERStat14-FR.pdf

New

Dec 2025

Regimen

PACL(W)+TRAS

Cancer Type:

Breast

Intent: Adjuvant

Funding:

New Drug Funding Program

Trastuzumab (Biosimilar) - Adjuvant Treatment for Breast Cancer

Drugs Used:

PACLitaxel,

trastuzumab